Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 2/20 | 0.49 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.49 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.47 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.46 |
| ▸ | DAO | P14920 | 1/20 | 0.46 |
| ▸ | NOS1 | P29475 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.44 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.44 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.44 |
| ▸ | LTA4H | P09960 | 1/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.43 |
| ▸ | PRKCI | P41743 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.41 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | NOS3 | P29474 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL241880 | 0.93 | CYP4F2 (0.53) | CYP4F2CYP4A11TBXA2RNOS1LTA4H | |
| SCHEMBL10922837 | 0.91 | CYP4F2 (0.51) | CYP4F2CYP4A11ENPP2TBXA2RDAO | |
| SCHEMBL11491469 | 0.86 | ENPP2 (0.50) | CYP4F2CYP4A11ENPP2DAONOS1 | |
| SCHEMBL238401 | 0.86 | CYP4F2 (0.58) | CYP4F2CYP4A11TBXA2RNOS1TDP1 | |
| SCHEMBL2138580 | 0.86 | TDP1 (0.56) | CYP4F2CYP4A11ENPP2DAONOS1 | |
| SCHEMBL2176833 | 0.84 | CYP4F2 (0.56) | CYP4F2CYP4A11TBXA2RNOS1IGF1R | |
| SCHEMBL80185 | 0.83 | CYP4A11 (0.58) | CYP4F2CYP4A11TBXA2RNOS1LTA4H | |
| SCHEMBL613331 | 0.83 | TAAR1 (0.48) | CYP4F2CYP4A11TBXA2RNOS1LTA4H | |
| SCHEMBL13959482 | 0.83 | TAAR1 (0.48) | ENPP2DAONOS1TSHRPRSS1 | |
| SCHEMBL8464457 | 0.83 | CYP4F2 (0.54) | CYP4F2CYP4A11TBXA2RLPLLIPG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104262921-B | A kind of bamboo fiber strengthens without styrene unsaturated polyester composite and preparation thereof | Fujian Agricultural and Forestry University (CN) | 2016-05-11 | — | — | CN | claimed |
| CN-104262921-A | Bamboo fiber reinforced styrene-free unsaturated polyester composite material and preparation method thereof | UNIV FUJIAN AGRIC & FORESTRY | 2015-01-07 | — | — | CN | claimed |
| US-9382188-B2 | Aromatic ring compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2016-07-05 | — | — | US | disclosed |
| CN-104262921-B | A kind of bamboo fiber strengthens without styrene unsaturated polyester composite and preparation thereof | Fujian Agricultural and Forestry University (CN) | 2016-05-11 | — | — | CN | disclosed |
| CN-104262921-B | A kind of bamboo fiber strengthens without styrene unsaturated polyester composite and preparation thereof | Fujian Agricultural and Forestry University (CN) | 2016-05-11 | — | — | CN | disclosed |
| CN-104262921-A | Bamboo fiber reinforced styrene-free unsaturated polyester composite material and preparation method thereof | UNIV FUJIAN AGRIC & FORESTRY | 2015-01-07 | — | — | CN | disclosed |
| EP-2816023-A1 | AROMATIC RING COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2014-12-24 | — | — | EP | disclosed |
| US-8476265-B2 | Compounds-801 | ASTRAZENECA AB (SE) | 2013-07-02 | — | — | US | disclosed |
| US-8476265-B2 | Compounds-801 | ASTRAZENECA AB (SE) | 2013-07-02 | — | — | US | disclosed |
| US-8476265-B2 | Compounds-801 | ASTRAZENECA AB (SE) | 2013-07-02 | — | — | US | disclosed |
| US-8455483-B2 | Compounds—801 | ASTRAZENECA AB (SE) | 2013-06-04 | — | — | US | disclosed |
| US-20130018037-A1 | Compounds - 801 | ASTRAZENECA UK LIMITED (GB) | 2013-01-17 | — | — | US | disclosed |
| US-20130018037-A1 | Compounds - 801 | ASTRAZENECA UK LIMITED (GB) | 2013-01-17 | — | — | US | disclosed |
| US-20130018037-A1 | Compounds - 801 | ASTRAZENECA UK LIMITED (GB) | 2013-01-17 | — | — | US | disclosed |
| EP-2459572-A2 | SPIROCYCLIC AMIDE DERIVATIVES | AstraZeneca AB (SE) | 2012-06-06 | — | — | EP | disclosed |
| US-20110053909-A1 | Compounds - 801 | PULMAGEN THERAPEUTICS (SYNERGY) LIMITED (GB) | 2011-03-03 | — | — | US | disclosed |
| US-20110053909-A1 | Compounds - 801 | PULMAGEN THERAPEUTICS (SYNERGY) LIMITED (GB) | 2011-03-03 | — | — | US | disclosed |
| US-20110053909-A1 | Compounds - 801 | PULMAGEN THERAPEUTICS (SYNERGY) LIMITED (GB) | 2011-03-03 | — | — | US | disclosed |
| WO-2011012896-A2 | COMPOUNDS - 801 | ASTRAZENECA AB (SE) | 2011-02-03 | — | — | WO | disclosed |
| WO-2011012896-A2 | COMPOUNDS - 801 | ASTRAZENECA AB (SE) | 2011-02-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130018037-A1 | Compounds - 801 | ADRA2C, ADRB2, ADRB1 | CYP4F2 874/4885CYP4A11 252/4885ENPP2 3495/4885 |
| US-20110053909-A1 | Compounds - 801 | ADRA2C, ADRB2, ADRB1 | CYP4F2 874/4885CYP4A11 252/4885ENPP2 3495/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.